-
Something wrong with this record ?
Anterior gradient 2 and mucin 4 expression mirrors tumor cell differentiation in pancreatic adenocarcinomas, but aberrant anterior gradient 2 expression predicts worse patient outcome in poorly differentiated tumors
V. Brychtova, M. Hermanova, P. Karasek, J. Lenz, I. Selingerova, B. Vojtesek, Z. Kala, R. Hrstka,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT13794
MZ0
CEP Register
- MeSH
- Adenocarcinoma metabolism pathology surgery MeSH
- Adult MeSH
- Carcinoma, Pancreatic Ductal metabolism pathology surgery MeSH
- Outcome Assessment, Health Care statistics & numerical data MeSH
- Immunohistochemistry MeSH
- Kaplan-Meier Estimate MeSH
- Cohort Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Mucin-4 metabolism MeSH
- Pancreatic Neoplasms metabolism pathology surgery MeSH
- Pancreatectomy MeSH
- Predictive Value of Tests MeSH
- Prognosis MeSH
- Proportional Hazards Models MeSH
- Proteins metabolism MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVES: This study aimed to determine anterior gradient 2 (AGR2) expression in biopsies from pancreatic ductal adenocarcinomas (PDACs) and to evaluate AGR2 as a potential independent prognostic factor. METHODS: Tissue sample sections from a cohort of 135 consecutive surgically resectable PDACs were subjected to semiquantitative immunohistochemical analysis of AGR2 and mucin 4 (MUC4) expression. RESULTS: Anterior gradient 2 was over-expressed in PDAC compared with normal ductal cells. Since tumor lesions of PDAC are heterogeneous and constitute structures with various differentiation states, expression of both AGR2 and MUC4 was evaluated in each separate component. Expression levels of both proteins reflected the degree of tumor differentiation. Generally, well differentiated regions of tumor lesions expressed high levels of both proteins, moderately differentiated regions showed less AGR2 and MUC4, and poorly differentiated structures showed only weak positivity or were entirely negative. Of particular interest were occasional cases of strong AGR2 expression in high-grade tumors, where elevated protein levels were associated with shorter patient survival. CONCLUSIONS: Anterior gradient 2 and MUC4 reflect the level of differentiation of PDACs. However, in less differentiated tumors, aberrantly elevated AGR2 expression predicts poor patient outcome.
§Department of Mathematics and Statistics Faculty of Science Masaryk University
‡Department of Complex Oncology Care Masaryk Memorial Cancer Institute
From the *Regional Centre for Applied Molecular Oncology Masaryk Memorial Cancer Institute
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14074553
- 003
- CZ-PrNML
- 005
- 20191021134632.0
- 007
- ta
- 008
- 141006s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MPA.0b013e3182a63bc3 $2 doi
- 035 __
- $a (PubMed)24177142
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Brychtová, Veronika $u From the *Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute; †First Department of Pathological Anatomy, St Anne's University Hospital, Medical Faculty of Masaryk University; ‡Department of Complex Oncology Care, Masaryk Memorial Cancer Institute; §Department of Mathematics and Statistics, Faculty of Science, Masaryk University; and ∥Department of Surgery, University Hospital Brno, Medical Faculty of Masaryk University, Brno, Czech Republic. $7 xx0228678
- 245 10
- $a Anterior gradient 2 and mucin 4 expression mirrors tumor cell differentiation in pancreatic adenocarcinomas, but aberrant anterior gradient 2 expression predicts worse patient outcome in poorly differentiated tumors / $c V. Brychtova, M. Hermanova, P. Karasek, J. Lenz, I. Selingerova, B. Vojtesek, Z. Kala, R. Hrstka,
- 520 9_
- $a OBJECTIVES: This study aimed to determine anterior gradient 2 (AGR2) expression in biopsies from pancreatic ductal adenocarcinomas (PDACs) and to evaluate AGR2 as a potential independent prognostic factor. METHODS: Tissue sample sections from a cohort of 135 consecutive surgically resectable PDACs were subjected to semiquantitative immunohistochemical analysis of AGR2 and mucin 4 (MUC4) expression. RESULTS: Anterior gradient 2 was over-expressed in PDAC compared with normal ductal cells. Since tumor lesions of PDAC are heterogeneous and constitute structures with various differentiation states, expression of both AGR2 and MUC4 was evaluated in each separate component. Expression levels of both proteins reflected the degree of tumor differentiation. Generally, well differentiated regions of tumor lesions expressed high levels of both proteins, moderately differentiated regions showed less AGR2 and MUC4, and poorly differentiated structures showed only weak positivity or were entirely negative. Of particular interest were occasional cases of strong AGR2 expression in high-grade tumors, where elevated protein levels were associated with shorter patient survival. CONCLUSIONS: Anterior gradient 2 and MUC4 reflect the level of differentiation of PDACs. However, in less differentiated tumors, aberrantly elevated AGR2 expression predicts poor patient outcome.
- 650 _2
- $a adenokarcinom $x metabolismus $x patologie $x chirurgie $7 D000230
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a duktální karcinom slinivky břišní $x metabolismus $x patologie $x chirurgie $7 D021441
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a Kaplanův-Meierův odhad $7 D053208
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mucin 4 $x metabolismus $7 D055264
- 650 _2
- $a hodnocení výsledků zdravotní péče $x statistika a číselné údaje $7 D017063
- 650 _2
- $a pankreatektomie $7 D010180
- 650 _2
- $a nádory slinivky břišní $x metabolismus $x patologie $x chirurgie $7 D010190
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a proporcionální rizikové modely $7 D016016
- 650 _2
- $a proteiny $x metabolismus $7 D011506
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hermanová, Markéta, $d 1969- $7 xx0073982
- 700 1_
- $a Karásek, Petr $7 xx0128590
- 700 1_
- $a Lenz, Jiří $7 xx0179491
- 700 1_
- $a Selingerová, Iveta $7 xx0169224
- 700 1_
- $a Vojtěšek, Bořivoj, $d 1960- $7 xx0001694
- 700 1_
- $a Kala, Zdeněk, $d 1960- $7 xx0003702
- 700 1_
- $a Hrstka, Roman $7 xx0077297
- 773 0_
- $w MED00003681 $t Pancreas $x 1536-4828 $g Roč. 43, č. 1 (2014), s. 75-81
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24177142 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20141006 $b ABA008
- 991 __
- $a 20191021135105 $b ABA008
- 999 __
- $a ok $b bmc $g 1042436 $s 873465
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 43 $c 1 $d 75-81 $i 1536-4828 $m Pancreas $n Pancreas $x MED00003681
- GRA __
- $a NT13794 $p MZ0
- LZP __
- $a Pubmed-20141006
